Dilatation, Pathologic: Clinical Trials

9 trials for Dilatation, Pathologic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed. 9 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 39Completed 9
Phase 22Completed 2

Follow Dilatation, Pathologic: new trials by email Literature Review of Dilatation, Pathologic trials Research Report on Dilatation, Pathologic

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Nyxol (0.75% Phentolamine Ophthalmic Solution) to Reverse Pharmacologically-Induced Mydriasis in Pediatric Subjects
Phentolamine Ophthalmic Solution 0.75%, Phentolamine Ophthalmic Solution Vehicle - Mydriasis, Dilation
Phase 3CompletedOpus Genetics, Inc232021-12-172026-10-30
Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) to Reverse Pharmacologically-Induced Mydriasis (MIRA-3)
Phentolamine Ophthalmic Solution 0.75%, Phentolamine Ophthalmic Solution Vehicle - Mydriasis, Dilation
Phase 3CompletedOpus Genetics, Inc3682021-11-182026-10-30
Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) to Reverse Pharmacologically-Induced Mydriasis
Phentolamine Ophthalmic Solution 0.75%, Phentolamine Ophthalmic Solution Vehicle (Placebo) - Mydriasis, Dilation
Phase 3CompletedOpus Genetics, Inc1852020-11-182026-10-30
Effect of Paracervical Block Volume on Pain Control for Dilation and Curettage.o
40cc buffered 0.5% lidocaine with 2 units of vasopressin paracervical block, 20cc 1% lidocaine with 2 units of vasopressin paracervical block - Abortion, Spontaneous, Abortion in First Trimester
Phase 3CompletedUniversity of California, San Diego1142018-10-292023-04-20
Hysteroscopy After Pretreatment With Misoprostol and Estradiol Trial
Misoprostol, Placebo - Cervical Ripening
Phase 3CompletedUllevaal University Hospital1002008-01-012009-05-25
Corneal Collagen Cross-Linking for the Treatment of Progressive Keratoconus and Corneal Ectasia
Corneal collagen, Sham comparator - Progressive Keratoconus, Corneal Ectasia
Phase 2 / Phase 3CompletedEmory University1602007-12-012010-09-02
Corneal Collagen Cross-Linking for Ectasia (CXL)
riboflavin ophthalmic solution, UVA Irradiation - Ectasia
Phase 3CompletedGlaukos Corporation1302007-12-012021-04-26
Hysteroscopy and Misoprostol Project
misoprostol and cervical ripening - Uterine Hemorrhage
Phase 3CompletedUllevaal University Hospital862006-09-012007-08-07
A Safety Study of AQUAVAN® (Fospropofol Disodium) Injection for Sedation During Minor Surgical Procedures.
AQUAVAN® (fospropofol disodium) Injection - Procedural Sedation
Phase 2 / Phase 3CompletedEisai Inc.1232006-05-012012-06-20

Narrower conditions

Mydriasis (3)  ·  Corneal Diseases (2)  ·  Abortion, Missed (1)  ·  Abortion, Spontaneous (1)  ·  Arteriovenous Fistula (1)  ·  Bunion (1)  ·  Keratoconus (1)  ·  Uterine Hemorrhage (1)

Broader conditions

Pathological Conditions, Anatomical (9)  ·  Pathological Conditions, Signs and Symptoms (9)  ·  Eye Diseases (5)  ·  Pupil Disorders (3)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Urogenital Diseases (2)  ·  Arteriovenous Malformations (1)  ·  Cardiovascular Abnormalities (1)  ·  Cardiovascular Diseases (1)  ·  Congenital Abnormalities (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Female Urogenital Diseases (1)  ·  Fistula (1)  ·  Foot Deformities (1)  ·  Foot Deformities, Acquired (1)

Interventions

Misoprostol (2)  ·  Cervical Ripening (1)  ·  Corneal Cross-Linking (1)  ·  Injections (1)  ·  Lidocaine (1)  ·  fospropofol (1)

Sponsors

Opus Genetics, Inc (3)  ·  Ullevaal University Hospital (2)  ·  Eisai Inc. (1)  ·  Emory University (1)  ·  Glaukos Corporation (1)  ·  University of California, San Diego (1)

Countries

United States (7)  ·  Norway (2)

Top investigators

Britt-Ingjerd Nesheim, MD PhD (1)  ·  Britt-Ingjerd Nesheim, MD, PhD (1)  ·  Charles Slonim, MD (1)  ·  James B Jones, MD, PharmD (1)  ·  Peter Hersh, MD (1)  ·  R. Doyle Stulting, MD, PhD (1)  ·  Sheila K Mody, MD MPH (1)

Results publications

PMID 41743463, PMID 22692521, PMID 25365551, PMID 35852274